Anti-obestic composition
Abstract
The composition of the present invention comprises (1) a biologically effective amount of an extract of a plant of the genus Eucalyptus as an active ingredient, and (2) a biologically acceptable carrier or diluent, and is effective for inhibiting or preventing obesity (increase in weight), lipid storage disease, hyperlipemia, arteriosclerosis, or thrombosis, and is also effective for inhibiting or reducing an amount of triglyceride or an amount of cholesterol in blood. Therefore, the composition of the present invention is used in the form of drugs, food products, food additives, animal feeds, and additives for animal feeds.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . An anti-obestic composition comprising:
(1) a biologically effective amount of an extract of a plant of the genus Eucalyptus as an active ingredient, and (2) a biologically acceptable carrier or diluent.
2 . A lipid storage inhibitor composition comprising:
(1) a biologically effective amount of an extract of a plant of the genus Eucalyptus as an active ingredient, and (2) a biologically acceptable carrier or diluent.
3 . An anti-lipemic composition comprising:
(1) a biologically effective amount of an extract of a plant of the genus Eucalyptus as an active ingredient, and (2) a biologically acceptable carrier or diluent.
4 . An anti-arteriosclerotic composition comprising:
(1) a biologically effective amount of an extract of a plant of the genus Eucalyptus as an active ingredient, and (2) a biologically acceptable carrier or diluent.
5 . An anti-thrombotic composition comprising:
(1) a biologically effective amount of an extract of a plant of the genus Eucalyptus as an active ingredient, and (2) a biologically acceptable carrier or diluent.
6 . A composition for inhibiting or reducing an amount of triglyceride, comprising:
(1) a biologically effective amount of an extract of a plant of the genus Eucalyptus as an active ingredient, and (2) a biologically acceptable carrier or diluent.
7 . A composition for inhibiting or reducing an amount of cholesterol in blood, comprising:
(1) a biologically effective amount of an extract of a plant of the genus Eucalyptus as an active ingredient, and (2) a biologically acceptable carrier or diluent.
8 . A method of inhibiting or preventing obesity, which comprises administering or ingesting a composition comprising:
(1) a biologically effective amount of an extract of a plant of the genus Eucalyptus as an active ingredient, and (2) a biologically acceptable carrier or diluent.
9 . A method of inhibiting or preventing lipid storage, which comprises administering a composition comprising:
(1) a biologically effective amount of an extract of a plant of the genus Eucalyptus as an active ingredient, and (2) a biologically acceptable carrier or diluent.
10 . A method of inhibiting or preventing hyperlipemia, which comprises administering a composition comprising:
(1) a biologically effective amount of an extract of a plant of the genus Eucalyptus as an active ingredient, and (2) a biologically acceptable carrier or diluent.
11 . A method of inhibiting or preventing arteriosclerosis, which comprises administering a composition comprising:
(1) a biologically effective amount of an extract of a plant of the genus Eucalyptus as an active ingredient, and (2) a biologically acceptable carrier or diluent.
12 . A method of inhibiting or preventing thrombosis, which comprises administering a composition comprising:
(1) a biologically effective amount of an extract of a plant of the genus Eucalyptus as an active ingredient, and (2) a biologically acceptable carrier or diluent.
13 . A method of inhibiting or reducing an amount of triglyceride in a host, which comprises administering a composition comprising:
(1) a biologically effective amount of an extract of a plant of the genus Eucalyptus as an active ingredient, and (2) a biologically acceptable carrier or diluent.
14 . A method of inhibiting or reducing an amount of cholesterol in blood, which comprises administering a composition comprising:
(1) a biologically effective amount of an extract of a plant of the genus Eucalyptus as an active ingredient, and (2) a biologically acceptable carrier or diluent.
15 . A method according to any one of claims 8 to 14 , wherein administration is accomplished by ingestion.Join the waitlist — get patent alerts
Track US2001036488A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.